Elon Musk’s Twitter Deal Is Proceeding, Not ‘On Hold,’ Executives Tell Staff

image

(Bloomberg) — Twitter Inc. executives told employees on Thursday that the $44 billion deal to sell the company to billionaire Elon Musk is moving forward as planned, and that they won’t renegotiate the agreed-upon price of $54.20 per share.

Vijaya Gadde, Twitter’s top lawyer and head of policy, also told workers at an all-hands meeting that there is “no such thing as a deal being on hold,” according to people who attended the meeting. She was pushing back on claims from Musk over the past week that he is pausing the deal while he learns more about the number of bots and spam accounts on the social-media service.

Twitter stock jumped about 2% on the news of the meeting, which was first reported by Bloomberg. Earlier the shares had declined by as much as 1.7%.

Other top Twitter executives, including Chief Executive Officer Parag Agrawal and finance chief Ned Segal, also addressed employees, said the people, who asked not to be identified discussing internal business. The companywide video call was intended for leadership to discuss the deal and provide more details following Twitter’s filing of its proxy statement with the Securities and Exchange Commission this week, which outlined the transaction’s history and terms.

Executives addressed a number of questions about the transaction, including whether Twitter would try and legally force Musk to buy the company based on his agreement. Gadde assured employees that Musk must “do everything he can” to make sure he gets his financing in order, and that it’s possible Twitter could try and “enforce” the terms of the deal “if we ever needed to do that in a court.” She added that getting to that step would be “pretty rare.”

Musk earlier this week suggested he would be interested in renegotiating his deal for Twitter. The company’s stock is currently trading at $37.45 per share, well below the offer price.

Thursday’s all-hands assembly was the latest in a string of internal meetings intended to help employees better understand the sales process. Segal discussed the gap in Twitter’s stock price and Musk’s offer, explaining to staff how this reflected some doubt that the deal would go through. He also said executives are still engaging with Musk and his team, and working with them “regularly” throughout the process to prepare for the possibilty of Musk taking over. Segal also discussed how Twitter’s board came to the decision to sell to Musk, which included an analysis of Twitter’s business projections if a deal didn’t happen.

Gadde added that she believes Musk will be able to vote his shares at Twitter’s annual shareholder meeting, which is scheduled for May 25. The shareholder vote on whether to approve the deal will take place at a later date.

Twitter has been in a state of limbo since the company’s board accepted an offer from Musk in late April. Musk has continued to criticize Twitter and its policies despite agreeing to the deal, and recently suggested the company was lying about the number of daily users that would be categorized as spam. He said the deal was “on hold” until he got more information. After Agrawal posted a long thread earlier this week explaining Twitter’s methodology for counting spam accounts, Musk replied to the CEO with a poop emoji.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Pharmaceutical Stocks To Buy Now

    Cumberland Pharmaceuticals Inc. (CPIX) Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing hospital acute care and gastroenterology drugs. The company provides innovative treatments for underserved... Read More

  • 3 Semiconductor Stocks To Buy Now

    Allegro MicroSystems, Inc. (ALGM) Allegro MicroSystems, Inc. is a semiconductor company specializing in power and sensing solutions. The company develops high-performance integrated circuits for automotive, industrial, and consumer applications, enhancing... Read More

  • 3 Pharma Stocks To Buy Now

    Arcutis Biotherapeutics, Inc. (ARQT) Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on developing innovative dermatology treatments. The company specializes in topical therapies for inflammatory skin conditions such as psoriasis... Read More

  • 3 Finance Stocks To Buy Now

    Hanover Insurance Group Inc. (THG) Hanover Insurance Group Inc. is a property and casualty insurance company providing coverage for businesses, individuals, and specialty markets. The company offers a range of... Read More

  • 3 Tech Service Stocks To Buy Now

    Sezzle Inc. (SEZL) Sezzle Inc. is a financial technology company that provides buy now, pay later (BNPL) solutions. The platform allows consumers to split purchases into interest-free installments, supporting merchants... Read More

  • 3 Insurance Stocks To Buy Now

    Employers Holdings Inc. (EIG) Employers Holdings Inc. is a specialty provider of workers’ compensation insurance for small businesses. The company focuses on cost-effective risk management solutions to help businesses maintain... Read More

  • 3 Medical Equipment Stocks To Buy Now

    STERIS plc (STE) STERIS plc is a global provider of infection prevention, decontamination, and surgical products for healthcare, pharmaceutical, and research industries. The company specializes in sterilization and surgical solutions... Read More

  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More